2022-2029年全球腫瘤學人工智慧分析解決方案市場規模研究與預測，按組件、癌症類型和區域分析。

2021年，全球腫瘤學人工智慧分析解決方案市場價值約為4519.9億美元，預計在2022-2029年的預測期內，將以超過35.50%的健康成長率成長。人工智慧在癌症實踐中的使用提供了臨床決策支援，主要用於處理癌症檢測、癌症診斷和篩查的醫療資料，或對病人預後的描述，並最佳化護理服務和臨床操作。癌症發病率的上升推動這個產業。這是因為世界各地的病例數量迅速增加。市場的主要驅動因素是癌症發病率的上升，對遠程醫療和遠程護理的需求不斷增加。此外，人工智慧在腫瘤學分析解決方案方面的進步，採用人工智慧進行疾病診斷，在2022-2029年的預測期內為市場創造了有利的成長機會。

癌症是全世界死亡的一個主要原因，根據世界衛生組織的數據，僅在2020年就有大約1000萬人死亡，佔所有死亡人數的近六分之一。世界衛生組織補充，吸煙、飲酒、高體重指數和缺乏運動鍛煉等因素會導致癌症。此外，患有肺癌的人感染COVID-19的機會更高。根據2022年12月發布的一份報告，在2018年1月1日至2022年7月2日期間，美國疾病控制和預防中心的國家生命統計系統中提到的死亡原因包括癌症。根據審查的資料，平均每週約有13,000例與癌症有關的死亡報告，在2018年和2019年，這種疾病是90%的病例的主要原因，2020年有88%的病例，2021年有87%的病例。然而，在這些困難的情況下，當代AI和ML技術有可能改善病人的診斷、護理和治療。大流行期間積壓的癌症成像問題用人工智慧解決了，這減少了醫務人員的負擔。然而，在2022-2029年的整個預測期內，腫瘤學人工智慧分析解決方案的高成本抑制了市場成長。

全球腫瘤學人工智慧分析解決方案市場研究考慮的主要地區包括亞太、北美、歐洲、拉美和世界其他地區。 2021年，北美洲控制了產業的佔有率。這種擴張歸因於數位基礎設施的可用性和政府的支援政策等因素。由於政府報銷的增加，腫瘤學服務預計將在該地區變得更受歡迎。亞太地區預計將在2023年至2030年期間經歷最快的成長。這一發展有幾個因素，包括印度和日本等國家老年人口的增加，以及醫院和診斷中心對數位技術的擴大使用，都可以歸功於此。

該研究的目的是確定近年來不同細分市場和國家的市場規模，並對未來幾年的價值進行預測。本報告旨在將研究涉及的國家內的產業的定性和定量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，還涵蓋了微觀市場的潛在機會，供利益相關者投資，以及對競爭格局和主要參與者的組件產品的詳細分析。

目錄

第一章：執行摘要

• 市場簡介
• 2019-2029年全球和細分市場的估計和預測
  • 2019-2029年，腫瘤學人工智慧分析解決方案市場，按地區分類
  • 2019-2029年，腫瘤學人工智慧分析解決方案市場，按組件分類
  • 2019-2029年，腫瘤學人工智慧分析解決方案市場，按癌症類型分類
• 主要趨勢
• 估算方法
• 研究假設

第二章：全球腫瘤學人工智慧分析解決方案市場的定義和範圍

• 本研究的目的
• 市場定義和範圍
  • 研究的範圍
  • 產業演變
• 研究中考慮的年份
• 貨幣兌換率

第三章：全球腫瘤學人工智慧分析解決方案市場動態

• 腫瘤學人工智慧分析解決方案的市場影響分析（2019-2029年）
  • 市場驅動力
    • 癌症的發病率不斷上升
    • 對遠程醫療和遠程護理的需求不斷增加
  • 市場挑戰
    • 腫瘤學人工智慧分析解決方案的成本高昂
  • 市場機會
    • 腫瘤學人工智慧在分析解決方案方面的進展
    • 採用人工智慧進行疾病診斷

第四章：全球腫瘤學人工智慧分析解決方案市場產業分析

• 波特的5力模型
  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭性的競爭
• 波特五力模型的未來方法（2019-2029年）
• PEST分析
  • 政治因素
  • 經濟
  • 社會
  • 技術
• 投資採用模式
• 分析師建議和結論
• 最佳投資機會
• 最佳策略

第五章：風險評估：COVID-19的影響

• 評估COVID-19對產業的整體影響
• COVID-19前和COVID-19後的市場情況

第六章：全球AI在腫瘤學中的分析解決方案市場，按組件分類

• 市場簡介
• 全球腫瘤學人工智慧分析解決方案市場，按組件，性能-潛力分析
• 2019-2029年全球腫瘤學人工智慧分析解決方案的市場估計和預測，按組件分類
• 腫瘤學人工智慧分析解決方案市場，細項分析
  • 資料授權服務
  • 軟體解決方案
  • 分析和其他服務

第7章：全球腫瘤學人工智慧分析解決方案市場，按癌症類型分類

• 市場簡介
• 按癌症類型分類的全球腫瘤學人工智慧分析解決方案市場，表現- 潛力分析
• 2019-2029年全球AI腫瘤學分析解決方案市場按癌症類型的估計和預測
• 腫瘤學人工智慧分析解決方案市場，細項分析
  • 乳腺癌
  • 肺癌
  • 前列腺癌
  • 結直腸癌
  • 腦瘤
  • 腎癌
  • 非霍奇金淋巴瘤
  • 膀胱癌

第八章：全球腫瘤學人工智慧分析解決方案市場，區域分析

• 腫瘤學人工智慧分析解決方案市場，區域市場簡介
• 北美洲
  • 美國
    • 2019-2029年組件細分的估計和預測
    • 癌症類型細分估計和預測，2019-2029年
  • 加拿大
• 歐洲腫瘤學人工智慧分析解決方案市場簡介
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 歐洲其他地區
• 亞太地區AI在腫瘤學中的分析解決方案市場簡介
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 亞太其他地區
• 拉美腫瘤學人工智慧分析解決方案市場簡介
  • 巴西
  • 墨西哥
• 世界其他地區

第九章：競爭情報

• 頂級市場戰略
• 公司簡介
  • Azra AI
    • 關鍵資訊
    • 概況
    • 財務（取決於數據的可用性）
    • 產品摘要
    • 近期發展情況
  • International Business Machines Corporation
  • Siemens Healthineers
  • Intel Corporation
  • GE Healthcare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • Concert.AI
  • Median Technologies
  • Path AI

第十章：研究過程

• 研究過程
  • 資料探勘
  • 數據分析
  • 市場評估
  • 驗證
  • 出版
• 研究屬性
• 研究假設

Global AI In Oncology for Analytical Solutions Market is valued at approximately USD 451.99 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 35.50% over the forecast period 2022-2029. The use of AI in cancer practice offers to supply clinical decision support majorly for processing medical data for cancer detection, cancer diagnosis and screening, or characterization of patient prognosis, and optimizing care delivery and clinical operations. The rising incidence of cancer is driving the industry. This is because the number of instances around the world is increasing quickly. The major driving factor for the market the is rising prevalence of cancer, the growing demand for telemedicine and remote care. Moreover, advancements in AI in oncology for analytical solutions, the adoption of AI for disease diagnosis is creating a lucrative growth opportunity for the market over the forecast period 2022-2029.

Cancer is a major cause of death worldwide, and according to the WHO, it was responsible for roughly 10 million deaths in 2020 alone, or nearly one-sixth of all deaths. The World Health Organization added that factors like tobacco use, alcohol consumption, a high body mass index, and a lack of physical exercise can cause cancer. Furthermore, individuals with lung cancer have a higher chance of contracting COVID-19. Among the causes of death mentioned in the National Vital Statistics System of the Centers for Disease Control and Prevention between January 1, 2018, and July 2, 2022, was cancer, according to a report released in December 2022. According to the data examined, there were approximately 13,000 cancer-related deaths reported weekly on average, with this illness being the primary cause in 90% of cases in 2018 and 2019, 88% of cases in 2020, and 87% of cases in 2021. However, in these difficult situations, contemporary AI and ML technologies have the potential to improve patient diagnosis, care, and treatment. The backlog of cancer imaging during the pandemic was addressed with artificial intelligence, which decreased the burden on the medical staff. However, the high cost of AI In Oncology For Analytical Solutions stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global AI In Oncology for Analytical Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2021, North America controlled the industry with a share. The expansion is ascribed to elements such as the availability of digital infrastructure and supportive governmental policies. Oncology services are anticipated to become more popular in the area as a result of increased government reimbursements. Asia Pacific is anticipated to experience the fastest increase between 2023 and 2030. Several factors, including the rising elderly population in nations such as India and Japan and the expanding use of digital technologies in hospitals and diagnostic centers, can be credited for this development.

Major market player included in this report are:

• Azra AI
• International Business Machines Corporation
• Siemens Healthineers
• Intel Corporation
• GE Healthcare
• NVIDIA Corporation
• Digital Diagnostics Inc.
• Concert.AI
• Median Technologies
• Path AI

Recent Developments in the Market:

• A group of scientists from the National Institutes of Health and Global Good created a machine learning algorithm that can analyze digital pictures of the cervix in women in 2019.
• The GI GeniusTM intelligent endoscopy module, which is driven by AI and aids healthcare professionals in the detection of colorectal cancer by improving visualization during colonoscopy, was introduced by Medtronic plc in August 2022 in India.

Global AI In Oncology for Analytical Solutions Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Component, Cancer Type, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Component offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Component:

• Data Licensing Services
• Software Solutions
• Analytics and Other Services

By Cancer Type:

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Kidney Cancer
• Non-Hodgkin Lymphoma
• Bladder Cancer

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. AI In Oncology for Analytical Solutions Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. AI In Oncology for Analytical Solutions Market, by Component, 2019-2029 (USD Billion)
  • 1.2.3. AI In Oncology for Analytical Solutions Market, by Cancer Type, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global AI In Oncology for Analytical Solutions Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global AI In Oncology for Analytical Solutions Market Dynamics

• 3.1. AI In Oncology for Analytical Solutions Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of cancer
    • 3.1.1.2. Growing demand for telemedicine and remote care
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of AI In Oncology for Analytical Solutions
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in AI in oncology for analytical solutions
    • 3.1.3.2. Adoption of AI for disease diagnosis

Chapter 4. Global AI In Oncology for Analytical Solutions Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global AI In Oncology for Analytical Solutions Market, by Component

• 6.1. Market Snapshot
• 6.2. Global AI In Oncology for Analytical Solutions Market by Component, Performance - Potential Analysis
• 6.3. Global AI In Oncology for Analytical Solutions Market Estimates & Forecasts by Component 2019-2029 (USD Billion)
• 6.4. AI In Oncology for Analytical Solutions Market, Sub Segment Analysis
  • 6.4.1. Data Licensing Services
  • 6.4.2. Software Solutions
  • 6.4.3. Analytics and Other Services

Chapter 7. Global AI In Oncology for Analytical Solutions Market, by Cancer Type

• 7.1. Market Snapshot
• 7.2. Global AI In Oncology for Analytical Solutions Market by Cancer Type, Performance - Potential Analysis
• 7.3. Global AI In Oncology for Analytical Solutions Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
• 7.4. AI In Oncology for Analytical Solutions Market, Sub Segment Analysis
  • 7.4.1. Breast Cancer
  • 7.4.2. Lung Cancer
  • 7.4.3. Prostate Cancer
  • 7.4.4. Colorectal Cancer
  • 7.4.5. Brain Tumor
  • 7.4.6. Kidney Cancer
  • 7.4.7. Non-Hodgkin Lymphoma
  • 7.4.8. Bladder Cancer

Chapter 8. Global AI In Oncology for Analytical Solutions Market, Regional Analysis

• 8.1. AI In Oncology for Analytical Solutions Market, Regional Market Snapshot
• 8.2. North America AI In Oncology for Analytical Solutions Market
  • 8.2.1. U.S. AI In Oncology for Analytical Solutions Market
    • 8.2.1.1. Component breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Cancer Type breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada AI In Oncology for Analytical Solutions Market
• 8.3. Europe AI In Oncology for Analytical Solutions Market Snapshot
  • 8.3.1. U.K. AI In Oncology for Analytical Solutions Market
  • 8.3.2. Germany AI In Oncology for Analytical Solutions Market
  • 8.3.3. France AI In Oncology for Analytical Solutions Market
  • 8.3.4. Spain AI In Oncology for Analytical Solutions Market
  • 8.3.5. Italy AI In Oncology for Analytical Solutions Market
  • 8.3.6. Rest of Europe AI In Oncology for Analytical Solutions Market
• 8.4. Asia-Pacific AI In Oncology for Analytical Solutions Market Snapshot
  • 8.4.1. China AI In Oncology for Analytical Solutions Market
  • 8.4.2. India AI In Oncology for Analytical Solutions Market
  • 8.4.3. Japan AI In Oncology for Analytical Solutions Market
  • 8.4.4. Australia AI In Oncology for Analytical Solutions Market
  • 8.4.5. South Korea AI In Oncology for Analytical Solutions Market
  • 8.4.6. Rest of Asia Pacific AI In Oncology for Analytical Solutions Market
• 8.5. Latin America AI In Oncology for Analytical Solutions Market Snapshot
  • 8.5.1. Brazil AI In Oncology for Analytical Solutions Market
  • 8.5.2. Mexico AI In Oncology for Analytical Solutions Market
• 8.6. Rest of The World AI In Oncology for Analytical Solutions Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Azra AI
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. International Business Machines Corporation
  • 9.2.3. Siemens Healthineers
  • 9.2.4. Intel Corporation
  • 9.2.5. GE Healthcare
  • 9.2.6. NVIDIA Corporation
  • 9.2.7. Digital Diagnostics Inc.
  • 9.2.8. Concert.AI
  • 9.2.9. Median Technologies
  • 9.2.10. Path AI

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global AI In Oncology for Analytical Solutions Market, report scope
• TABLE 2. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Component 2019-2029 (USD Billion)
• TABLE 4. Global AI In Oncology for Analytical Solutions Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
• TABLE 5. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global AI In Oncology for Analytical Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global AI In Oncology for Analytical Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row AI In Oncology for Analytical Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row AI In Oncology for Analytical Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global AI In Oncology for Analytical Solutions Market
• TABLE 70. List of primary sources, used in the study of global AI In Oncology for Analytical Solutions Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global AI In Oncology for Analytical Solutions Market, research methodology
• FIG 2. Global AI In Oncology for Analytical Solutions Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global AI In Oncology for Analytical Solutions Market, key trends 2021
• FIG 5. Global AI In Oncology for Analytical Solutions Market, growth prospects 2022-2029
• FIG 6. Global AI In Oncology for Analytical Solutions Market, porters 5 force model
• FIG 7. Global AI In Oncology for Analytical Solutions Market, pest analysis
• FIG 8. Global AI In Oncology for Analytical Solutions Market, value chain analysis
• FIG 9. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global AI In Oncology for Analytical Solutions Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global AI In Oncology for Analytical Solutions Market, regional snapshot 2019 & 2029
• FIG 15. North America AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 16. Europe AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America AI In Oncology for Analytical Solutions Market 2019 & 2029 (USD Billion)
• FIG 19. Global AI In Oncology for Analytical Solutions Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable